{
  "title": "Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer",
  "url": "https://ascopubs.org/doi/10.1200/OA-25-00051",
  "summary": [
    {
      "type": "bullet",
      "text": "**KEY FINDING**: 67% patient compliance achieved, improving study integrity."
    },
    {
      "type": "bullet",
      "text": "**TACTICAL WIN [SHIP NOW]**: Integrate AI to predict completion times and optimize schedules."
    },
    {
      "type": "bullet",
      "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: New regulatory guidelines demand PRO integration in trials by Q3 2025."
    },
    {
      "type": "bullet",
      "text": "**CONCERN**: Potential self-selection bias among patients opting for ePRO platforms."
    }
  ],
  "model": "granite4:tiny-h"
}